Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
作者信息
Carradori Simone
机构信息
Department of Pharmacy "G. d'Annunzio" University of Chieti-Pescara Via dei Vestini 31, 66100, Chieti, Italy.
出版信息
Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85-87. doi: 10.2174/1871523019999200228100917.
Abstract
摘要
相似文献
1
Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?目前针对新型冠状病毒肺炎有哪些可用的治疗选择？
Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85-87. doi: 10.2174/1871523019999200228100917.
2
Cationic drugs and COVID-19.阳离子药物与 COVID-19。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420966078. doi: 10.1177/2058738420966078.
3
Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.重组人血管紧张素转换酶2：新型冠状病毒感染及其并发症的潜在治疗方法
Acta Pharmacol Sin. 2020 Sep;41(9):1255-1257. doi: 10.1038/s41401-020-0430-6. Epub 2020 Jun 24.
4
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.溶酶体：SARS-CoV-2 感染性与尼曼-匹克病 C 型之间的潜在连接点，具有治疗意义。
FASEB J. 2020 Jun;34(6):7253-7264. doi: 10.1096/fj.202000654R. Epub 2020 May 5.
5
Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.从过敏学家的角度看 COVID-19 的分子机制和流行病学。
J Allergy Clin Immunol. 2020 Aug;146(2):285-299. doi: 10.1016/j.jaci.2020.05.033. Epub 2020 Jul 2.
6
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
7
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.当前用于管理新型冠状病毒病 2019（COVID-19）的药理学方法及其利用的原理：综述。
Rev Med Virol. 2020 Sep;30(5):e2136. doi: 10.1002/rmv.2136. Epub 2020 Jul 9.
8
Understanding of COVID-19 based on current evidence.基于现有证据对 COVID-19 的理解。
J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.
9
Uncertainty about the Efficacy of Remdesivir on COVID-19.瑞德西韦对COVID-19疗效的不确定性。
J Korean Med Sci. 2020 Jun 15;35(23):e221. doi: 10.3346/jkms.2020.35.e221.
10
COVID-19: A Defining Moment for Clinical Pharmacology?新型冠状病毒肺炎：临床药理学的决定性时刻？
Clin Pharmacol Ther. 2020 Jul;108(1):11-15. doi: 10.1002/cpt.1876.
引用本文的文献
1
Natural Products Database Screening for the Discovery of Naturally Occurring SARS-Cov-2 Spike Glycoprotein Blockers.天然产物数据库筛选以发现天然存在的严重急性呼吸综合征冠状病毒2刺突糖蛋白阻滞剂
ChemistrySelect. 2020 Nov 13;5(42):13309-13317. doi: 10.1002/slct.202003349. Epub 2020 Nov 16.
Zotero 插件